Compare ACET & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACET | FRD |
|---|---|---|
| Founded | 1947 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Steel/Iron Ore |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.3M | 139.3M |
| IPO Year | N/A | N/A |
| Metric | ACET | FRD |
|---|---|---|
| Price | $0.52 | $20.67 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 2.9M | 22.3K |
| Earning Date | 11-05-2025 | 02-06-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | N/A | ★ 43.48 |
| EPS | N/A | ★ 1.63 |
| Revenue | N/A | ★ $510,450,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $12.68 |
| Revenue Growth | N/A | ★ 8.72 |
| 52 Week Low | $0.45 | $12.24 |
| 52 Week High | $1.11 | $23.50 |
| Indicator | ACET | FRD |
|---|---|---|
| Relative Strength Index (RSI) | 43.00 | 54.84 |
| Support Level | $0.47 | $20.40 |
| Resistance Level | $0.52 | $21.79 |
| Average True Range (ATR) | 0.04 | 0.76 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 45.30 | 75.23 |
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.